Answer
Yes—very rare, severe respiratory toxicity, sometimes progressing to acute respiratory distress syndrome (ARDS), has been reported during sulfamethoxazole + trimethoprim (co-trimoxazole) treatment; suspected ARDS requires discontinuation and appropriate treatment.
Sources for this answer
- Co-Trimoxazole 40 mg/200 mg per 5 ml Paediatric SuspensionAspen · emc · SmPC §4.4 Special warnings and precautions for use · Version 13Document updated
Sources checked